Wir verwenden Cookies, um für diese Website Funktionen wie z.B. Login, einen Warenkorb oder die Sprachwahl zu ermöglichen. Weiterhin nutzen wir für anonymisierte, statistische Auswertungen der Nutzung Google Analytics, welches Cookies setzt. Mehr Informationen finden Sie in unserer Datenschutzerklärung.
OK, ich bin einverstanden Ich möchte keine Google Analytics-Cookies
International Journal of Oral Implantology
Login:
Benutzername:

Kennwort:

Plattform:

Kennwort vergessen?

Registrieren

Int J Oral Implantol (Berl) 5 (2012), Nr. 2     2. Aug. 2012
Int J Oral Implantol (Berl) 5 (2012), Nr. 2  (02.08.2012)

Seite 165-173, PubMed:22866292, Sprache: Englisch


Efficacy of quick-release lornoxicam versus placebo for acute pain management after dental implant surgery: a randomised placebo-controlled triple-blind trial
Bölükbasi, Nilüfer / Ersanli, Selim /Basegmez, Cansu / Özdemir, Tayfun / Özyalcin, Süleyman
Aim: To assess the efficacy of quick-release lornoxicam (LNX) on patient-reported acute pain after dental implant surgery.
Materials and methods: The study included subjects in good general health, aged 18 to 65 and scheduled to receive a maximum of three implants in the same quadrant. Participants received either 8 mg LNX or placebo and were asked to use the medications in case of pain in the first 120 min after implant surgery. Assessment of efficacy was performed using self-assessment questionnaires for the evaluation of pain intensity and pain relief for 12 h post dosing. Patients were also asked to record the rescue analgesic number. Evaluation of patient satisfaction was assessed using a 7-point scale. Safety was evaluated by the incidence of adverse events.
Results: A total of 83 (LNX/placebo, 42/41) patients who met the inclusion criteria and finished the evaluation period were included in the study. The proportion of patients experiencing postoperative pain was significantly lower in the LNX-treated group compared to the placebo group. Patients in the LNX group reported significantly higher pain relief scores than the placebo group. Twenty-nine patients in the placebo group and 6 patients in the LNX group used rescue analgesics. The number of used rescue analgesics was 1.024 ± 0.79 and 0.167 ± 0.43 in the placebo and LNX groups, respectively. The level of patient satisfaction was significantly higher in the LNX-treated patients (P = 0.007). No adverse events were reported during the study period.
Conclusions: Quick-release LNX is effective in postoperative acute pain control and has a high safety profile following dental implant surgery.

Schlagwörter: dental implant, lornoxicam, NSAIDs, pain
Volltext (keine Berechtigung) einzeln als PDF kaufen (20.00 €)Endnote-Export